5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size.
about
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancersCharacterization of lung cancer by amide proton transfer (APT) imaging: an in-vivo study in an orthotopic mouse modelOverdiagnosis in low-dose computed tomography screening for lung cancerPulmonary Nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry.Low-dose CT: technique, reading methods and image interpretation.Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT.Diagnosis and management of pulmonary nodules.[Research progress of treatment strategy for pulmonary nodule].Evaluating the growth of pulmonary nodular ground-glass opacity on CT: comparison of volume rendering and thin slice images.In vivo growth of 60 non-screening detected lung cancers: a computed tomography study.Reply: stage distribution of lung cancers detected by computed tomography screening in the NELSON Trial.Malignant solitary pulmonary nodules: assessment of mass growth rate and doubling time at follow-up CT.Screening for early stage lung cancer and its correlation with lung nodule detection.
P2860
Q27025828-5A1AAE1E-BEC8-4BA1-B152-D52FF757102AQ28387198-17355EBD-FEFA-4ED5-B722-735DA23602A9Q28534416-BD95221D-6829-4192-8C11-93F5C795FB9CQ33691938-765B24E5-C7E3-446E-9629-2C790D7CCE07Q35700935-AEBF15DC-5217-4943-8574-443DF463A31BQ36602229-A5D5C20B-F1CF-483B-BBD5-A4579A8F64BEQ37600536-E4851DFD-B442-421A-9068-E61FDDE30804Q38242760-957F529C-3F03-409B-B87E-FF66EA677221Q44749056-0E4FDC6A-1F60-4B25-BBAB-B815102E1B7BQ51472187-9FF0903F-6967-4E81-B5ED-BF10C04C119CQ52591138-DC5FDE38-7F47-4E32-BA84-0F6B5B32E07BQ54757693-98D40B04-AC9F-4E91-AAD4-63FCA9077611Q55101738-14F2252C-008A-4690-90D3-8BD71E079A3BQ55154062-4B1339DD-A87F-4B94-B0EE-E65CA639D16F
P2860
5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
5-year lung cancer screening e ...... on, stage, survival, and size.
@en
5-year lung cancer screening e ...... on, stage, survival, and size.
@nl
type
label
5-year lung cancer screening e ...... on, stage, survival, and size.
@en
5-year lung cancer screening e ...... on, stage, survival, and size.
@nl
prefLabel
5-year lung cancer screening e ...... on, stage, survival, and size.
@en
5-year lung cancer screening e ...... on, stage, survival, and size.
@nl
P2093
P2860
P356
P1433
P1476
5-year lung cancer screening e ...... on, stage, survival, and size.
@en
P2093
David E Midthun
James R Jett
Jayawant N Mandrekar
Rebecca M Lindell
Stephen J Swensen
Thomas E Hartman
P2860
P304
P356
10.1378/CHEST.09-0915
P407
P577
2009-07-06T00:00:00Z